ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL2420 |
|
117086-68-7 |
Ricasetron 98+% |
C19H27N3O | |
CL2260 |
|
96441-14-4 |
Labetalone Hydrochloride 98+% |
C19H23ClN2O3 | |
CLA1343 |
|
1384260-65-4 |
Aducanumab (Anti-Amyloid-β ) 95+% |
— | |
CLA1313 |
|
1318075-13-6 |
Simtuzumab (Anti-LOXL2) 95+% |
— | |
CLA1279 |
|
1095207-05-8 |
Crenezumab (Anti-Amyloid Beta) 95+% |
— | |
CLA1224 |
|
955085-14-0 |
Solanezumab (Anti-Amyloid-β) 95+% |
— | |
CLA1192 |
|
1260393-98-3 |
Lecanemab (Anti-Amyloid Beta) 95+% |
— | |
CLA1170 |
|
1043556-46-2 |
Gantenerumab (Anti-Amyloid β) 95+% |
— | |
CL2265 |
|
123040-16-4 |
Azasetron Hydrochloride; Azasetron HCl 98+% |
C17H21Cl2N3O3 | |
CL2218 |
|
67469-78-7 |
GBR-12909 Dihydrochloride; Vanoxerine Dihydrochloride 98+% |
C28H34Cl2F2N2O | |
CL2171 |
|
127586-66-7 |
NO-711ME; NO711 Methyl ester; 3-Pyridinecarboxylic acid, 1-[2- [[(diphenylmethylene)amino]oxy] ethyl]-1,2,5,6 -tetrahydro-, methyl ester 95+% |
C22H24N2O3 | |
CL2148 |
|
93479-97-1 |
Glimepiride 98+% |
C24H34N4O5S | |
CL2003 |
|
31932-87-3 |
(RS)-3-Hydroxyphenylglycine 98+% |
C8H9NO3 | |
CL1973 |
|
81409-90-7 |
Cabergoline 98+% |
C26H37N5O2 | |
CL1312A |
|
158930-17-7 |
Frovatriptan Succinate Monohydrate 98+% |
C18H25N3O6 | |
CL1166 |
|
603148-36-3 |
Azeliragon (TTP488) 98+% |
C32H38ClN3O2 | |
CL1181 |
|
503070-58-4 |
Vilanterol Trifenatate/Vilanterol Trifenate 98+% |
C44H49Cl2NO7 | |
CL1130 |
|
101-26-8 |
Pyridostigmine Bromide 99+% |
C9H13BrN2O2 | |
HL1027 |
|
4429-63-4 |
Tabersonine 98+% |
C21H24N2O2 | |
CL1966 |
|
367514-87-2 |
Lurasidone
|
C28H36N4O2S | |